Antidote: Lipitor

Share this article:
As a fan, prescriber, and consumer of Pfizer's blockbuster cholesterol-lowering statin drug Lipitor, I've long joked that in addition to increasing exercise and improving diet, patients with a high cholesterol should consider eating their hot fudge sundaes with a dose of Lipitor on top. This idea was meant as a joke, but now a London study published in the American Journal of Cardiology has taken the idea seriously. The authors analyzed study data from 42,800 patients and determined that while a 7-oz fast food cheeseburger and a small milkshake increases the risk of developing heart disease by 23%, on the other hand taking most statin drugs decreases the risk by 29%.                                                                 

So, should fast food chains be handing out Lipitor with the burgers? Should there be an item on McDonald's menu called a “McStatin”?  

Statins are extremely useful. Lipitor is the world's top selling branded drug, with almost $13 billion per year in sales. The widely publicized 2008 JUPITER trial would seem to confirm this widespread use. This study gave a lot of credence to what we doctors call “primary prevention,” a justification for giving statin drugs to patients before they develop heart disease.                                                  

So why not hand out a statin with every double cheeseburger? Well for one thing, these meds are mostly effective when they are taken on a regular basis, not episodically. Your best treatment for high cholesterol is to improve your diet and to exercise regularly, not to take more visits to a fast food joint and pop a pill while you are there.   

Marc Siegel, MD, is an internist and professor of medicine at New York University and the author of False Alarm: The Truth About the Epidemic of Fear
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?